<p>Survival curves of DEC1 expression in ESCC patients analyzed by Kaplan-Meier method.</p
<p>Kaplan-Meier survival curves for CV events according to E/E’ (>15) and LAVI (>32 mL/m<sup>2</sup>...
<p>(A) Curves calculated for FoxQ1 expression. High expression in the FoxQ1 group (red line) indicat...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...
<p>(A) Cases stratified based on the overall maspin expression, (B) levels of maspin staining in the...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>(A) Kaplan-Meier plots for the Disease-specific survival (DSS) rate of ESCC patients with (n = 12...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>(A) The 5-year overall survival rate of 168 ESCC patients was 30.26%. (B) The 5-year overall surv...
<p>(A) Kaplan-Meier survival curves of patients with survivin mRNA above (black squares) or under th...
<p>Univariate and multivariate analyses of overall survival among patients with ESCC.</p
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>The Kaplan-Meier survival curves of patients with positive TRIM24 expression and negative TRIM24 ...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>Kaplan-Meier survival curves for CV events according to E/E’ (>15) and LAVI (>32 mL/m<sup>2</sup>...
<p>(A) Curves calculated for FoxQ1 expression. High expression in the FoxQ1 group (red line) indicat...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...
<p>(A) Cases stratified based on the overall maspin expression, (B) levels of maspin staining in the...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>(A) Kaplan-Meier plots for the Disease-specific survival (DSS) rate of ESCC patients with (n = 12...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>(A) The 5-year overall survival rate of 168 ESCC patients was 30.26%. (B) The 5-year overall surv...
<p>(A) Kaplan-Meier survival curves of patients with survivin mRNA above (black squares) or under th...
<p>Univariate and multivariate analyses of overall survival among patients with ESCC.</p
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>The Kaplan-Meier survival curves of patients with positive TRIM24 expression and negative TRIM24 ...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>Kaplan-Meier survival curves for CV events according to E/E’ (>15) and LAVI (>32 mL/m<sup>2</sup>...
<p>(A) Curves calculated for FoxQ1 expression. High expression in the FoxQ1 group (red line) indicat...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
DOI
Add to ORKG